The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
The global Soliris market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Prior to COVID-19, the China market for Soliris was anticipated to grow from US$ 43.15 million in 2020 to US$ 105.67 million by 2026; it is expected to grow at a CAGR of 14.86% during 2021–2026, whereas post-COVID-19 scenario, the market for Soliris is projected to grow from US$ 40.9 million in 2020 (a change by ~-6.4% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ 100.58 million by 2026; it is expected to grow at a CAGR of 14.75% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Soliris market.The classification of Soliris includes Plasma Exchange and Plasma Infusion, and the proportion of Plasma Exchange in 2019 is about 76.36%, and the proportion is in increasing trend from 2013 to 2018.
Soliris is widely used for patients of PNH, aHUS and other. The most proportion of Soliris is used for patients of PNH, and the proportion in 2019 is 66.85%.
This report aims to provide a comprehensive presentation of the global market for Soliris, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Soliris.
Report Scope
The Soliris market size, estimations, and forecasts are provided in terms of sales volume (Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Soliris market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Soliris manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alexion
Segment by Type
Plasma Exchange
Plasma Infusion
Segment by Application
PNH
aHUS
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Soliris manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Soliris in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
The global Soliris market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Prior to COVID-19, the China market for Soliris was anticipated to grow from US$ 43.15 million in 2020 to US$ 105.67 million by 2026; it is expected to grow at a CAGR of 14.86% during 2021–2026, whereas post-COVID-19 scenario, the market for Soliris is projected to grow from US$ 40.9 million in 2020 (a change by ~-6.4% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ 100.58 million by 2026; it is expected to grow at a CAGR of 14.75% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Soliris market.The classification of Soliris includes Plasma Exchange and Plasma Infusion, and the proportion of Plasma Exchange in 2019 is about 76.36%, and the proportion is in increasing trend from 2013 to 2018.
Soliris is widely used for patients of PNH, aHUS and other. The most proportion of Soliris is used for patients of PNH, and the proportion in 2019 is 66.85%.
This report aims to provide a comprehensive presentation of the global market for Soliris, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Soliris.
Report Scope
The Soliris market size, estimations, and forecasts are provided in terms of sales volume (Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Soliris market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Soliris manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alexion
Segment by Type
Plasma Exchange
Plasma Infusion
Segment by Application
PNH
aHUS
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Soliris manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Soliris in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Soliris Market Overview
1.1 Product Overview and Scope of Soliris
1.2 Soliris Segment by Type
1.2.1 Global Soliris Market Value Comparison by Type (2024-2030)
1.2.2 Plasma Exchange
1.2.3 Plasma Infusion
1.3 Soliris Segment by Application
1.3.1 Global Soliris Market Value by Application: (2024-2030)
1.3.2 PNH
1.3.3 aHUS
1.3.4 Other
1.4 Global Soliris Market Size Estimates and Forecasts
1.4.1 Global Soliris Revenue 2019-2030
1.4.2 Global Soliris Sales 2019-2030
1.4.3 Global Soliris Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Soliris Market Competition by Manufacturers
2.1 Global Soliris Sales Market Share by Manufacturers (2019-2024)
2.2 Global Soliris Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Soliris Average Price by Manufacturers (2019-2024)
2.4 Global Soliris Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Soliris, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Soliris, Product Type & Application
2.7 Soliris Market Competitive Situation and Trends
2.7.1 Soliris Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Soliris Players Market Share by Revenue
2.7.3 Global Soliris Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Soliris Retrospective Market Scenario by Region
3.1 Global Soliris Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Soliris Global Soliris Sales by Region: 2019-2030
3.2.1 Global Soliris Sales by Region: 2019-2024
3.2.2 Global Soliris Sales by Region: 2025-2030
3.3 Global Soliris Global Soliris Revenue by Region: 2019-2030
3.3.1 Global Soliris Revenue by Region: 2019-2024
3.3.2 Global Soliris Revenue by Region: 2025-2030
3.4 North America Soliris Market Facts & Figures by Country
3.4.1 North America Soliris Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Soliris Sales by Country (2019-2030)
3.4.3 North America Soliris Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Soliris Market Facts & Figures by Country
3.5.1 Europe Soliris Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Soliris Sales by Country (2019-2030)
3.5.3 Europe Soliris Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Soliris Market Facts & Figures by Country
3.6.1 Asia Pacific Soliris Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Soliris Sales by Country (2019-2030)
3.6.3 Asia Pacific Soliris Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Soliris Market Facts & Figures by Country
3.7.1 Latin America Soliris Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Soliris Sales by Country (2019-2030)
3.7.3 Latin America Soliris Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Soliris Market Facts & Figures by Country
3.8.1 Middle East and Africa Soliris Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Soliris Sales by Country (2019-2030)
3.8.3 Middle East and Africa Soliris Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Soliris Sales by Type (2019-2030)
4.1.1 Global Soliris Sales by Type (2019-2024)
4.1.2 Global Soliris Sales by Type (2025-2030)
4.1.3 Global Soliris Sales Market Share by Type (2019-2030)
4.2 Global Soliris Revenue by Type (2019-2030)
4.2.1 Global Soliris Revenue by Type (2019-2024)
4.2.2 Global Soliris Revenue by Type (2025-2030)
4.2.3 Global Soliris Revenue Market Share by Type (2019-2030)
4.3 Global Soliris Price by Type (2019-2030)
5 Segment by Application
5.1 Global Soliris Sales by Application (2019-2030)
5.1.1 Global Soliris Sales by Application (2019-2024)
5.1.2 Global Soliris Sales by Application (2025-2030)
5.1.3 Global Soliris Sales Market Share by Application (2019-2030)
5.2 Global Soliris Revenue by Application (2019-2030)
5.2.1 Global Soliris Revenue by Application (2019-2024)
5.2.2 Global Soliris Revenue by Application (2025-2030)
5.2.3 Global Soliris Revenue Market Share by Application (2019-2030)
5.3 Global Soliris Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Alexion
6.1.1 Alexion Corporation Information
6.1.2 Alexion Description and Business Overview
6.1.3 Alexion Soliris Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Alexion Soliris Product Portfolio
6.1.5 Alexion Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Soliris Industry Chain Analysis
7.2 Soliris Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Soliris Production Mode & Process
7.4 Soliris Sales and Marketing
7.4.1 Soliris Sales Channels
7.4.2 Soliris Distributors
7.5 Soliris Customers
8 Soliris Market Dynamics
8.1 Soliris Industry Trends
8.2 Soliris Market Drivers
8.3 Soliris Market Challenges
8.4 Soliris Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
